Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-08

Clinical Trial Update: Activated Charcoal Use in Chronic Kidney Disease Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating activated charcoal in patients with end-stage renal disease and other chronic kidney disease conditions; recruitment is o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Activated Charcoal (activated charcoal)

Snippet

Sponsor: Mansoura University | Conditions: End Stage Renal Disease (ESRD), CKD 5D, Hemodialysis | Phase 2 | Status: RECRUITING